🚀 VC round data is live in beta, check it out!
Dr. Miele Cosmed Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Dr. Miele Cosmed Group and similar public comparables like Culti Milano, Comvita, Jacques Bogart, Hain Celestial Group and more.
Dr. Miele Cosmed Group Overview
About Dr. Miele Cosmed Group
Dr Miele Cosmed Group SA is engaged in manufacturing cosmetics and household chemicals for national and international retailers, fulfils consumer needs in the sector of personal care, hygiene and cleanliness. The company's brands include Apart, Biophen, Mole, Bobini, Sofin and Izo.
Founded
1986
HQ
Employees
723
Website
Sectors
Financials (FY)
EV
$78M
Dr. Miele Cosmed Group Financials
Dr. Miele Cosmed Group reported last fiscal year revenue of $136M and EBITDA of $17M.
In the same fiscal year, Dr. Miele Cosmed Group generated $58M in gross profit, $17M in EBITDA, and $10M in net income.
Dr. Miele Cosmed Group P&L
In the most recent fiscal year, Dr. Miele Cosmed Group reported revenue of $136M and EBITDA of $17M.
Dr. Miele Cosmed Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $136M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $58M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 43% | XXX | XXX | XXX |
| EBITDA | — | XXX | $17M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 12% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 10% | XXX | XXX | XXX |
| Net Profit | — | XXX | $10M | XXX | XXX | XXX |
| Net Margin | — | XXX | 7% | XXX | XXX | XXX |
| Net Debt | — | — | $9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Dr. Miele Cosmed Group Stock Performance
Dr. Miele Cosmed Group has current market cap of $62M, and enterprise value of $78M.
Market Cap Evolution
Dr. Miele Cosmed Group's stock price is $0.72.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $78M | $62M | 0.1% | XXX | XXX | XXX | $0.12 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDr. Miele Cosmed Group Valuation Multiples
Dr. Miele Cosmed Group trades at 0.6x EV/Revenue multiple, and 4.6x EV/EBITDA.
Dr. Miele Cosmed Group Financial Valuation Multiples
As of April 20, 2026, Dr. Miele Cosmed Group has market cap of $62M and EV of $78M.
Equity research analysts estimate Dr. Miele Cosmed Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Dr. Miele Cosmed Group has a P/E ratio of 6.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $62M | XXX | $62M | XXX | XXX | XXX |
| EV (current) | $78M | XXX | $78M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 4.6x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 6.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.3x | XXX | XXX | XXX |
| P/E | — | XXX | 6.2x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 14.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Dr. Miele Cosmed Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Dr. Miele Cosmed Group Margins & Growth Rates
Dr. Miele Cosmed Group's revenue in the last fiscal year grew by 10%.
Dr. Miele Cosmed Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Dr. Miele Cosmed Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 10% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 39% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Dr. Miele Cosmed Group Public Comps
See public comps and valuation multiples for other Health & Beauty comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Dr. Miele Cosmed Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Culti Milano | XXX | XXX | XXX | XXX | XXX | XXX |
| Comvita | XXX | XXX | XXX | XXX | XXX | XXX |
| Jacques Bogart | XXX | XXX | XXX | XXX | XXX | XXX |
| Hain Celestial Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Suominen | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dr. Miele Cosmed Group M&A Activity
Dr. Miele Cosmed Group acquired XXX companies to date.
Last acquisition by Dr. Miele Cosmed Group was on XXXXXXXX, XXXXX. Dr. Miele Cosmed Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Dr. Miele Cosmed Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDr. Miele Cosmed Group Investment Activity
Dr. Miele Cosmed Group invested in XXX companies to date.
Dr. Miele Cosmed Group made its latest investment on XXXXXXXX, XXXXX. Dr. Miele Cosmed Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Dr. Miele Cosmed Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Dr. Miele Cosmed Group
| When was Dr. Miele Cosmed Group founded? | Dr. Miele Cosmed Group was founded in 1986. |
| Where is Dr. Miele Cosmed Group headquartered? | Dr. Miele Cosmed Group is headquartered in Poland. |
| How many employees does Dr. Miele Cosmed Group have? | As of today, Dr. Miele Cosmed Group has over 723 employees. |
| Is Dr. Miele Cosmed Group publicly listed? | Yes, Dr. Miele Cosmed Group is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Dr. Miele Cosmed Group? | Dr. Miele Cosmed Group trades under DMG ticker. |
| When did Dr. Miele Cosmed Group go public? | Dr. Miele Cosmed Group went public in 2013. |
| Who are competitors of Dr. Miele Cosmed Group? | Dr. Miele Cosmed Group main competitors are Culti Milano, Comvita, Jacques Bogart, Hain Celestial Group. |
| What is the current market cap of Dr. Miele Cosmed Group? | Dr. Miele Cosmed Group's current market cap is $62M. |
| What is the current revenue of Dr. Miele Cosmed Group? | Dr. Miele Cosmed Group's last fiscal year revenue is $136M. |
| What is the current EV/Revenue multiple of Dr. Miele Cosmed Group? | Current revenue multiple of Dr. Miele Cosmed Group is 0.6x. |
| Is Dr. Miele Cosmed Group profitable? | No, Dr. Miele Cosmed Group is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.